Home » Topics » Regulatory

Regulatory
RSS

FDA approves Organon's short-acting neuromuscular blocker Raplon

Aug. 19, 1999

FDA approves Cleocin vaginal ovules for treatment of bacterial vaginosis

Aug. 19, 1999

Etanercept trial results in psoriatic arthritis announced

Aug. 18, 1999

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Aug. 16, 1999

Bayer will launch new quinolone on September 1

Aug. 13, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

CPMP adopts positive opinion concerning reformulated Norvir capsules

Aug. 13, 1999

FDA further expands approved indications for Zocor

Aug. 11, 1999

Fujisawa announced setback in launch data for Protopic

Aug. 10, 1999

U.K.'s MCA is first to approve Synercid for marketing

Aug. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...